Sculptra(TM) has a broad cosmetic
application and is suitable for
increasing the volume of depressed areas, particularly to correct skin
depressions - such as skin creases, wrinkles, folds, scars, eye rings -
and
for aging skin. It is also suitable for large volume corrections of fat
loss
mainly due to normal aging. Injected below the surface of the skin in
the area
of fat loss, Sculptra(TM) provides a gradual and significant increase in
skin
firmness, improving the appearance of folds and sunken areas. Injections
can
only be performed by a trained physician and the treatment involves
minimal
downtime. "As we age, we lose
volume in our face. Sculptra(TM) allows us to restore
the fullness of a more youthful face; think about the analogy of a
raisin and
a grape," says Dr. Julie Khanna, plastic surgeon and director of the
Institute
of Cosmetic & Laser Surgery in Oakville, Ontario. "Clients who have
tried
Sculptra(TM) say they now look as young as they feel and are pleased to
see
that Scultpra(TM) delivers on its promise of natural-looking results and
a
restored, youthful appearance." Sculptra(TM) is a synthetic polymer from the alpha-hydroxy acid family
(fruit acids) that is biocompatible, biodegradable and has been widely
used
for more than 30 years in dissolvable sutures and soft-tissue
implants.(2)
Possible side effects of Sculptra(TM) may include the delayed formation
of
small papules under the skin in the treated area particularly when the
product
is over-concentrated. These papules are generally not visible and may
only be
noticed when pressing on the treated area. Other side effects may
include
injection-related events at the site of injection, such as bleeding,
tenderness or discomfort, redness, bruising or swelling. For more information, visit
www.sculptra.ca. The new website also
includes a search tool to easily locate a local Sculptra(TM)-trained
physician
across Canada. Health Canada approved Sculptra(TM) in June 2006 and more
than 70 dermatologists and plastic surgeons across Canada have been
treating
patients since the fall of 2006. Sculptra(TM) is marketed by Dermik, the
dermatology division of sanofi-aventis Canada Inc.
About sanofi-aventis
Sanofi-aventis is one of the world's leading pharmaceutical companies.
Backed by a world-class R&D organization, sanofi-aventis is developing
leading
positions in seven major therapeutic areas: cardiovascular, thrombosis,
oncology, metabolic diseases, central nervous system, internal medicine,
and
vaccines. Sanofi-aventis is listed in Paris (EURONEXT : SAN) and in New
York
(NYSE : SNY). In Canada, sanofi-aventis Canada Inc. employs over 1,140
people
and has its headquarters in Laval, Quebec.
(1) Vleggaar D,. Facial Volumetric Correction with Injectable
Poly-L-Lactic Acid. Dermatol Surg. 2005; 31:1511-1518.
(2) Thioly-Bensoussan, D. Journal of the European Academy of Dermatology
and Venereology. 2006; Vol 20: 14.
|
